India mulls adopting international standards on drug inspections, manufacturing
29 April 2015
India's pharmaceutical regulators are considering whether to take the rigid steps necessary to join international drug inspection systems. The actions are considered necessary if India is to become more of an exporting nation, but some pharmas are cautious.
28 April 2015
Spark Therapeutics, Inc. (NASDAQ: ONCE) and Clearside Biomedical, Inc. announced today that they have entered into an option agreement under which Spark acquired exclusive rights to license Clearside's microinjector technology to deliver gene therapies to the back of the eye. Under the agreement, the companies will explore the feasibility of using Clearside's microinjector technology to deliver viral vectors to the choroid and the retina through the suprachoroidal space (SCS).
Pharmaceutical Companies Buy Rivals’ Drugs, Then Jack Up the Prices
28 April 2015
More pharmaceutical companies are buying drugs that they see as undervalued, then raising the prices. It is one of a number of industry tactics, along with companies regularly upping the prices of their own older medicines and launching new treatments at once unheard of sums, driving up the cost of drugs.
Virus Protects From Other Viruses
28 April 2015
An ancient retrovirus that's been integrated into the human genome appears to become reactivated during embryonic development to help ward off other viral invaders, Carl Zimmer writes at the New York Times.
Decline in U.S. science spending threatens economy, security: MIT
28 April 2015
Warning of an "innovation deficit," scientists at the Massachusetts Institute of Technology say declining government spending on basic research is holding back potentially life-saving advances in 15 fields, from robotics and fusion energy to Alzheimer's disease and agriculture.
Why Cross-Country Comparisons on Drug Prices are Misleading
28 April 2015
Too often, critics greatly exaggerate price differences between the U.S. and other countries to create an erroneous impression that medicines are a major driver of U.S. health care cost growth – ignoring that medicines account for a small share of health spending differences between the U.S. and other countries. They also fail to acknowledge the ramifications of centralized price control policies other countries use to achieve whatever price differences do exist.
New study examines the potential value proposition of retail clinics
27 April 2015
Retail health clinics are now a part of the health care landscape with the potential to become a much more powerful enabler of a “culture of health,” according to a recent report by Manatt Health, the health care division of Manatt, Phelps & Phillips.
China steps up decentralized drug industry regulation, market prices push
27 April 2015
China authorities at the highest level are acting on legislation that would, among other things, decentralize drug industry regulation and free some price controls.
Device companies team up to launch Asia Pacific Medical Technology Association in Singapore
27 April 2015
Industry bigwigs are teaming up to create the first medical device industry association focused solely on Asia. The member companies of the just-launched Asia Pacific Medical Technology Association (APACMed) include Abbott, Baxter, B. Braun, Becton Dickinson, Boston Scientific, Cardinal Health, GE Healthcar, Johnson & Johnson, Medtronic, Philips, Siemens, Stryker and Zimmer.
Marinus Pharmaceuticals insider Gail M. Farfel Sells 30,000 Shares (MRNS)
24 April 2015
Marinus Pharmaceuticals (NASDAQ:MRNS) insider Gail M. Farfel sold 30,000 shares of Marinus Pharmaceuticals stock on the open market in a transaction that occurred on Tuesday, April 21st. The stock was sold at an average price of $9.48, for a total value of $284,400.00.
06 September 2024
NovaMedica expands its line of products for the treatment of Alzheimer’s disease
22 August 2024
Children visited the NovaMedica Innotech pharmaceutical manufacturing facility
14 June 2024
87% of cancer patients give positive ratings for medical care quality
18 September 2024
The Russian market of fillers and biorevitalizers grew by 21% in the first half of 2024
18 September 2024
Pharma’s Patient Reach Problem: Billions Still Left Behind
17 September 2024
17 September 2024